- Home
- DALN vs LSB Comparison
DALN vs LSB Comparison
Compare DALN & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DALN
- LSB
- Stock Information
- Founded
- DALN 1954
- LSB 2002
- Country
- DALN United States
- LSB China
- Employees
- DALN N/A
- LSB N/A
- Industry
- DALN Newspapers/Magazines
- LSB
- Sector
- DALN Consumer Discretionary
- LSB
- Exchange
- DALN Nasdaq
- LSB NYSE
- Market Cap
- DALN 38.1M
- LSB 31.5M
- IPO Year
- DALN 2008
- LSB N/A
- Fundamental
- Price
- DALN $4.36
- LSB $1.14
- Analyst Decision
- DALN
- LSB
- Analyst Count
- DALN 0
- LSB 0
- Target Price
- DALN N/A
- LSB N/A
- AVG Volume (30 Days)
- DALN 24.5K
- LSB 17.9K
- Earning Date
- DALN 04-30-2025
- LSB 06-21-2025
- Dividend Yield
- DALN N/A
- LSB N/A
- EPS Growth
- DALN N/A
- LSB N/A
- EPS
- DALN 5.56
- LSB N/A
- Revenue
- DALN $123,414,000.00
- LSB $79,415,311.00
- Revenue This Year
- DALN N/A
- LSB $39.33
- Revenue Next Year
- DALN N/A
- LSB $75.61
- P/E Ratio
- DALN $0.78
- LSB N/A
- Revenue Growth
- DALN N/A
- LSB N/A
- 52 Week Low
- DALN $2.98
- LSB $1.15
- 52 Week High
- DALN $7.86
- LSB $11.20
- Technical
- Relative Strength Index (RSI)
- DALN 42.22
- LSB 28.76
- Support Level
- DALN $4.25
- LSB $1.16
- Resistance Level
- DALN $4.62
- LSB $1.28
- Average True Range (ATR)
- DALN 0.32
- LSB 0.09
- MACD
- DALN 0.00
- LSB 0.02
- Stochastic Oscillator
- DALN 7.46
- LSB 0.00
About DALN DallasNews Corporation Series A
DallasNews Corp is a local news and information publishing company in Texas with commercial printing, distribution, and direct mail capabilities, as well as a presence in emerging media and digital marketing.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.